OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 01, 2023
Innovations in downstream processing accelerate development, enhance efficiency, and promote sustainability.
August 02, 2023
Scale-up strategies for cell culture will require a deep understanding of overall bioprocess workflows.
June 01, 2023
Scaling cell therapy production workflows requires the establishment of closed, automated steps.
May 18, 2023
Jane True, vice-president of mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, shares her perspective on how mRNA will shift commercial models in the pharmaceutical industry.
February 02, 2023
Improvement in viral vector yield has become integral to new cell and gene therapy product development.
September 16, 2022
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
September 01, 2022
Scaling up chromatography resins requires a thorough understanding of their intended use.
August 02, 2022
Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
April 02, 2022
The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.
November 23, 2021
Takeda has exercised an option to co-develop and co-commercialize an investigational, brain-penetrant progranulin replacement therapy for the potential treatment of frontotemporal dementia-granulin.